O’Brien, S. M., Jaglowski, S., Byrd, J. C., Bannerji, R., Blum, K. A., Fox, C. P., . . . Coutre, S. E. (2018). Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials. JAMA Oncol.
Styl cytowania ChicagoO’Brien, Susan M., et al. "Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials." JAMA Oncol 2018.
Styl cytowania MLAO’Brien, Susan M., et al. "Prognostic Factors for Complete Response to Ibrutinib in Patients With Chronic Lymphocytic Leukemia: A Pooled Analysis of 2 Clinical Trials." JAMA Oncol 2018.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..